Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway

Although gemcitabine is the standard chemotherapy treatment for advanced pancreatic cancer, its benefits are quite limited due to prevalent chemoresistance, and the mechanism underlying gemcitabine chemoresistance remains unclear. Currently, Nrf2 has been deemed as a significant contributor to gemci...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Yukai, Ye, Wen, Huang, Chaohao, Yu, Dinglai, Chen, Hao, Deng, Tuo, Zhang, Fan, Lou, Bin, Zhang, Jie, Shi, Keqing, Chen, Bicheng, Zhou, Mengtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932458/
https://www.ncbi.nlm.nih.gov/pubmed/29849873
http://dx.doi.org/10.1155/2018/2360427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932458/
https://www.ncbi.nlm.nih.gov/pubmed/29849873
http://dx.doi.org/10.1155/2018/2360427

Ejemplares similares